Wiley.com
Print this page Share

Defining Optimal Immunotherapies for Type 1 Diabetes

Gregory R. Bock (Editor), Jamie A. Goode (Editor)
ISBN: 978-0-470-72325-8
Hardcover
222 pages
December 2008
List Price: US $235.00
Government Price: US $135.63
Enter Quantity:   Buy
Defining Optimal Immunotherapies for Type 1 Diabetes (0470723254) cover image

  • This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).
  • Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.
  • The book integrates information from human and animal studies.
  • The book considers T1D within the broader context of autoimmune disease.
  • The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.

Related Titles

More From This Series

Genetic Effects on Environmental Vulnerability to Disease
by Sir Michael J. Rutter (Editor)
Novel and Re-emerging Respiratory Viral Diseases
by Gregory R. Bock (Editor), Jamie A. Goode (Editor)
Growth Factors and Psychiatric Disorders
by Derek J. Chadwick (Editor), Jamie A. Goode (Editor)
The Biology of Extracellular Molecular Chaperones
by Derek J. Chadwick (Editor), Jamie A. Goode (Editor)
Cortical Development: Genes and Genetic Abnormalities
by Gregory R. Bock (Editor), Jamie A. Goode (Editor)

More By These Authors

Vascular Development
Dietary Supplements and Health
Tinkering: The Microevolution of Development
Acetaldehyde-Related Pathology: Bridging the Trans-Disciplinary Divide
Decoding the Genomic Control of Immune Reactions
Back to Top